Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pregnancy-Induced | 7 | 2024 | 77 | 3.520 |
Why?
|
| Postpartum Period | 11 | 2025 | 213 | 2.750 |
Why?
|
| Pre-Eclampsia | 5 | 2023 | 223 | 2.470 |
Why?
|
| Cardiovascular Diseases | 6 | 2024 | 1863 | 1.870 |
Why?
|
| Diabetes, Gestational | 3 | 2024 | 109 | 1.600 |
Why?
|
| Myocardial Ischemia | 3 | 2024 | 332 | 1.540 |
Why?
|
| Heart Arrest | 3 | 2024 | 340 | 1.410 |
Why?
|
| Pregnancy Complications | 4 | 2025 | 507 | 1.320 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 478 | 1.220 |
Why?
|
| Pregnancy | 16 | 2025 | 7161 | 0.940 |
Why?
|
| Hemodynamic Monitoring | 1 | 2023 | 12 | 0.880 |
Why?
|
| Puerperal Disorders | 1 | 2023 | 46 | 0.850 |
Why?
|
| Vein of Galen Malformations | 1 | 2022 | 7 | 0.830 |
Why?
|
| Cerebral Veins | 1 | 2022 | 16 | 0.820 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 50 | 0.810 |
Why?
|
| Cerebrovascular Disorders | 1 | 2023 | 117 | 0.800 |
Why?
|
| Metabolic Syndrome | 2 | 2022 | 330 | 0.780 |
Why?
|
| Heart Failure | 3 | 2024 | 2127 | 0.770 |
Why?
|
| Embolization, Therapeutic | 1 | 2022 | 227 | 0.680 |
Why?
|
| Stroke | 1 | 2023 | 958 | 0.490 |
Why?
|
| Stillbirth | 2 | 2024 | 79 | 0.410 |
Why?
|
| Maine | 4 | 2025 | 7 | 0.410 |
Why?
|
| Female | 17 | 2025 | 65550 | 0.370 |
Why?
|
| Risk Factors | 6 | 2024 | 10015 | 0.350 |
Why?
|
| Contraception | 2 | 2024 | 59 | 0.270 |
Why?
|
| Humans | 18 | 2025 | 123224 | 0.270 |
Why?
|
| Rural Population | 2 | 2025 | 251 | 0.250 |
Why?
|
| Depression | 2 | 2023 | 1217 | 0.230 |
Why?
|
| Prospective Studies | 3 | 2025 | 6040 | 0.220 |
Why?
|
| Gonorrhea | 1 | 2023 | 36 | 0.220 |
Why?
|
| Chlamydia Infections | 1 | 2023 | 45 | 0.220 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1309 | 0.220 |
Why?
|
| Cardiac Output | 1 | 2023 | 169 | 0.210 |
Why?
|
| Vascular Resistance | 1 | 2023 | 189 | 0.210 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2025 | 420 | 0.210 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2022 | 50 | 0.190 |
Why?
|
| Ambulatory Care | 1 | 2025 | 377 | 0.190 |
Why?
|
| Monitoring, Physiologic | 1 | 2023 | 360 | 0.180 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 1306 | 0.180 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2024 | 459 | 0.170 |
Why?
|
| Mental Health | 1 | 2023 | 346 | 0.170 |
Why?
|
| Infant, Newborn | 2 | 2023 | 8108 | 0.170 |
Why?
|
| Cohort Studies | 3 | 2025 | 4710 | 0.170 |
Why?
|
| Adult | 6 | 2025 | 29072 | 0.160 |
Why?
|
| Premature Birth | 1 | 2022 | 380 | 0.140 |
Why?
|
| Infant, Premature | 1 | 2022 | 799 | 0.130 |
Why?
|
| Pandemics | 1 | 2023 | 1101 | 0.120 |
Why?
|
| Hospitalization | 1 | 2023 | 1726 | 0.120 |
Why?
|
| United States | 4 | 2024 | 10637 | 0.070 |
Why?
|
| Young Adult | 3 | 2024 | 8865 | 0.060 |
Why?
|
| Birth Intervals | 1 | 2024 | 2 | 0.060 |
Why?
|
| Insurance Claim Review | 1 | 2024 | 27 | 0.060 |
Why?
|
| Chlamydia trachomatis | 1 | 2023 | 21 | 0.060 |
Why?
|
| Contraceptive Agents | 1 | 2023 | 14 | 0.050 |
Why?
|
| Sexual Partners | 1 | 2023 | 85 | 0.050 |
Why?
|
| Contact Tracing | 1 | 2023 | 57 | 0.050 |
Why?
|
| California | 1 | 2022 | 128 | 0.050 |
Why?
|
| Counseling | 1 | 2023 | 219 | 0.050 |
Why?
|
| Urban Population | 1 | 2023 | 221 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 16033 | 0.040 |
Why?
|
| Recurrence | 1 | 2024 | 1423 | 0.040 |
Why?
|
| Risk | 1 | 2022 | 747 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 406 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 398 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2024 | 444 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 866 | 0.040 |
Why?
|
| Vaccination | 1 | 2024 | 950 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2022 | 1168 | 0.040 |
Why?
|
| Patient Safety | 1 | 2022 | 394 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2024 | 3249 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 2025 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 2406 | 0.030 |
Why?
|
| Adolescent | 2 | 2024 | 19110 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 26016 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2022 | 3316 | 0.030 |
Why?
|
ACKERMAN-BANKS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(75)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_